FT NYSE Arca Biotechnology UE A/ IE00BL0L0H60 /
| NAV5/29/2023 | Chg.-0.0010 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 18.8700USD | -0.01% | reinvestment | Equity Worldwide | First Trust Advisors ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | - | - | - | - | - | 1.42 | -1.12 | -3.19 | -2.15 | -2.79 | 5.56 | 4.23 | - |
| 2021 | 4.23 | -4.04 | -4.62 | 2.37 | -0.73 | 5.94 | -2.66 | 3.41 | -4.49 | -0.08 | -5.54 | 3.34 | -3.71% |
| 2022 | -8.06 | -1.63 | 1.78 | -8.94 | -0.69 | 0.53 | 3.37 | -2.77 | -3.12 | 8.59 | 8.45 | -0.68 | -4.69% |
| 2023 | 5.92 | -6.00 | 0.86 | -0.96 | 0.59 | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 16.95% | 18.45% | 23.28% | 23.25% | -% |
| Sharpe ratio | -0.20 | 0.11 | 0.34 | -0.25 | - |
| Best month | +5.92% | +8.45% | +8.59% | +8.59% | - |
| Worst month | -6.00% | -6.00% | -6.00% | -8.94% | - |
| Maximum loss | -10.44% | -10.44% | -14.13% | -33.37% | - |
| Outperformance | - | - | - | - | - |
All quotes in USD
Performance
| YTD | +0.04% | ||
|---|---|---|---|
| 6 Months | +2.68% | ||
| 1 Year | +11.40% | ||
| 3 Years | -6.71% | ||
| 5 Years | - | ||
| 10 Years | - | ||
| Since start | -5.65% | ||
| Year | |||
| 2022 | -4.69% | ||
| 2021 | -3.71% | ||